Breaking News Instant updates and real-time market news.

CDNA

CareDx

$23.06

-3.14 (-11.98%)

07:26
11/04/19
11/04
07:26
11/04/19
07:26

CareDx announces launch of AlloSure 3.0

CareDx announces the launch of AlloSure 3.0, the next iteration in continued transplant patient-focused improvements. CareDx has new data showing AlloSure provides more in-depth insights into patients with TCMR1A and borderline rejection. Data suggests the heterogeneous pattern of these diagnoses is associated with varying degrees of organ injury. The prospective, multicenter analysis across leading transplant centers shows that AlloSure remained low in patients that continued to have a stable clinical profile and was elevated in patients that had declining clinical profiles. This highlights the ability to use AlloSure to better risk stratify transplant patients with borderline, TCMR1A, and subclinical rejection.

CDNA CareDx
$23.06

-3.14 (-11.98%)

09/26/19
PIPR
09/26/19
NO CHANGE
Target $63
PIPR
Overweight
CareDx remains a top small cap pick at Piper Jaffray
Following an expert call with Dr. Stanley Jordan from Cedars-Sinai, Piper Jaffray analyst William Quirk says CareDx remains a top small cap pick with an Overweight rating and $63 price target. Jordan spoke highly of AlloSure and said it has been a helpful test to identify kidney transplant rejections early and avoid unnecessary biopsies, Quirk tells investors in a research note. Further, the doctor was confident test utility will expand with more research, adds the analyst. Quirk remains confident in CareDx's position in the kidney transplant market.
10/01/19
CHLM
10/01/19
INITIATION
Target $48
CHLM
Buy
CareDx assumed with a Buy at Craig-Hallum
Craig-Hallum analyst Alexander Nowak assumed coverage of CareDx with a Buy rating and $48 price target. The analyst argues that the company "goes beyond AlloSure kidney," and believes it is becoming "the transplant company." Further, Nowak sees CareDx poised to show the free cash flow potential in two years' time.
10/01/19
10/01/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Banco Santander (SAN) resumed with a Neutral at Citi. 2. Blackstone (BX) initiated with an Outperform at Wells Fargo. 3. Agree Realty (ADC) initiated with a Buy at Berenberg. 4. CareDx (CDNA) assumed with a Buy at Craig-Hallum. 5. Acadia (ACAD) initiated with an Outperform at RBC Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/01/19
PIPR
11/01/19
NO CHANGE
Target $63
PIPR
Overweight
CareDx continues to build 'moat around transplant,' says Piper Jaffray
CareDx reported revenue growth in Q3 of 60% year-over-year to $33.8M, above the Street's estimate of $33.1M, Piper Jaffray analyst William Quirk tells investors in a research note. The analyst believes CareDx continues to build its "moat around transplant" by gaining access to the entire continuum of transplant care. The K-OAR study is expected to finish enrolling in early 2020, and enrollment for the OKRA registry study for KidneyCare began in September, he points out. Quirk, who is also encouraged by the recent draft Local Coverage Determination for AlloSure heart, says CareDx remains a top small-cap idea with an Overweight rating and $63 price target.

TODAY'S FREE FLY STORIES

09:58
12/09/19
12/09
09:58
12/09/19
09:58
Conference/Events
JPMorgan oil services/equip analyst to hold an analyst/industry conference call »

Oil Services &…

PCG

PG&E

$11.30

1.65 (17.10%)

, SIG

Signet Jewelers

$21.05

0.48 (2.33%)

09:55
12/09/19
12/09
09:55
12/09/19
09:55
Options
Early notable gainers among liquid option names on December 9th »

Notable gainers among…

PCG

PG&E

$11.30

1.65 (17.10%)

SIG

Signet Jewelers

$21.05

0.48 (2.33%)

SWKS

Skyworks

$104.20

2.8 (2.76%)

FCX

Freeport McMoRan

$11.97

0.33 (2.84%)

FTV

Fortive

$75.51

2.65 (3.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 07

    Jan

09:55
12/09/19
12/09
09:55
12/09/19
09:55
Conference/Events
JPMorgan homebuilding analyst to hold an analyst/industry conference call »

Homebuilding &…

09:55
12/09/19
12/09
09:55
12/09/19
09:55
Conference/Events
JPMorgan business services analyst to hold analyst/industry conference call »

Business &…

FTSV

Forty Seven

$17.61

3.21 (22.29%)

09:53
12/09/19
12/09
09:53
12/09/19
09:53
Hot Stocks
Breaking Hot Stocks news story on Forty Seven »

Forty Seven trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

TTWO

Take-Two

$119.55

-4.21 (-3.40%)

09:53
12/09/19
12/09
09:53
12/09/19
09:53
Recommendations
Take-Two analyst commentary  »

Take-Two's BioShock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

HY

Hyster-Yale Materials

$60.47

0.66 (1.10%)

09:52
12/09/19
12/09
09:52
12/09/19
09:52
Conference/Events
Hyster-Yale Materials management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 26

    Feb

ZS

Zscaler

$47.38

0.66 (1.41%)

09:50
12/09/19
12/09
09:50
12/09/19
09:50
Options
Funky call sale in ZScaler at market-open »

Funky call sale in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

  • 16

    Dec

RTRX

Retrophin

$13.31

0.05 (0.38%)

09:50
12/09/19
12/09
09:50
12/09/19
09:50
Conference/Events
Retrophin management to meet with JMP Securities »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

ARQL

ArQule

$19.61

9.94 (102.79%)

, LLY

Eli Lilly

$119.52

-0.07 (-0.06%)

09:49
12/09/19
12/09
09:49
12/09/19
09:49
Conference/Events
Wolfe Research biotech analyst to hold an analyst/industry webcast »

Biotech Analyst Tewari…

ARQL

ArQule

$19.61

9.94 (102.79%)

LLY

Eli Lilly

$119.52

-0.07 (-0.06%)

MRK

Merck

$88.76

-0.08 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 11

    Dec

  • 17

    Dec

  • 17

    Dec

  • 24

    Jan

  • 24

    Jan

  • 30

    Jan

  • 05

    Feb

  • 14

    Mar

XFOR

X4 Pharmaceuticals

$10.60

(0.00%)

09:48
12/09/19
12/09
09:48
12/09/19
09:48
Upgrade
X4 Pharmaceuticals rating change  »

X4 Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTSV

Forty Seven

$15.86

1.46 (10.14%)

09:48
12/09/19
12/09
09:48
12/09/19
09:48
Hot Stocks
Breaking Hot Stocks news story on Forty Seven »

Forty Seven trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

KOS

Kosmos

$5.41

-0.62 (-10.28%)

09:47
12/09/19
12/09
09:47
12/09/19
09:47
Hot Stocks
Kosmos falls -10.6% »

Kosmos is down -10.6%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UGAZ

VelocityShares 3x Long Natural Gas ETN

$7.93

-1.42 (-15.19%)

09:47
12/09/19
12/09
09:47
12/09/19
09:47
Hot Stocks
VelocityShares 3x Long Natural Gas ETN falls -15.2% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPLO

Diplomat Pharmacy

$3.97

-1.855 (-31.87%)

09:47
12/09/19
12/09
09:47
12/09/19
09:47
Hot Stocks
Diplomat Pharmacy falls -31.7% »

Diplomat Pharmacy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPCE

Virgin Galactic

$8.04

0.76 (10.44%)

09:47
12/09/19
12/09
09:47
12/09/19
09:47
Hot Stocks
Virgin Galactic rises 10.4% »

Virgin Galactic is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

PCG

PG&E

$11.05

1.4 (14.51%)

09:47
12/09/19
12/09
09:47
12/09/19
09:47
Hot Stocks
PG&E rises 14.7% »

PG&E is up 14.7%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$180.50

24.71 (15.86%)

09:47
12/09/19
12/09
09:47
12/09/19
09:47
Hot Stocks
VelocityShares 3x Inv Natural Gas ETN rises 16.0% »

VelocityShares 3x Inv…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RBB

RBB Bancorp

$20.42

(0.00%)

09:45
12/09/19
12/09
09:45
12/09/19
09:45
Conference/Events
RBB Bancorp management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

  • 12

    Dec

09:45
12/09/19
12/09
09:45
12/09/19
09:45
General news
Treasury 3-year auction outlook: the $38 B sale leads off »

Treasury 3-year auction…

TTWO

Take-Two

$123.76

(0.00%)

09:44
12/09/19
12/09
09:44
12/09/19
09:44
Hot Stocks
Take-Two says newly-formed 'Cloud Chamber' studio developing next BioShock game »

2K, a publishing label of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

ALPN

Alpine Immune Sciences

$3.02

(0.00%)

09:40
12/09/19
12/09
09:40
12/09/19
09:40
Hot Stocks
Alpine Immune Sciences presents ALPN-101 Phase 1 healthy volunteer study data »

Alpine Immune Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JBLU

JetBlue

$19.03

(0.00%)

, SPCE

Virgin Galactic

$7.28

(0.00%)

09:40
12/09/19
12/09
09:40
12/09/19
09:40
Options
Unusually active option classes on open December 9th »

Unusual total active…

JBLU

JetBlue

$19.03

(0.00%)

SPCE

Virgin Galactic

$7.28

(0.00%)

CHWY

Chewy

$24.93

(0.00%)

VLO

Valero

$93.62

(0.00%)

DELL

Dell Technologies

$47.09

(0.00%)

CRWD

Crowdstrike

$50.89

(0.00%)

ZS

Zscaler

$46.72

(0.00%)

LULU

Lululemon

$229.50

(0.00%)

CGC

Canopy Growth

$18.65

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 10

    Dec

  • 11

    Dec

  • 12

    Dec

  • 16

    Dec

  • 27

    Feb

  • 09

    Dec

KALV

KalVista

$14.36

0.25 (1.77%)

, MRK

Merck

$88.84

0.09 (0.10%)

09:37
12/09/19
12/09
09:37
12/09/19
09:37
Recommendations
KalVista, Merck analyst commentary  »

Roth says KalVista trial…

KALV

KalVista

$14.36

0.25 (1.77%)

MRK

Merck

$88.84

0.09 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

  • 17

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

PSTL

Postal Realty Trust

$15.85

0.15 (0.96%)

09:34
12/09/19
12/09
09:34
12/09/19
09:34
Conference/Events
Postal Realty Trust management to meet with DA Davidson »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.